Kameswaran Surendran

Dr. Kameswaran Surendran

Pediatrics and Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2007 in Development
Verified
Journal Article
Closed access
PDF file
HCHui-Teng Cheng
Hui-Teng Cheng
MKMijin Kim
Mijin Kim
MVM. Todd Valerius
M. Todd Valerius
Kameswaran SurendranKameswaran Surendran
Kameswaran Surendran
KSKarin Schuster-Gossler
Karin Schuster-Gossler
RKRaphael Kopan
Raphael Kopan
The Notch pathway regulates cell fate determination in numerous developmental processes. Here we report that Notch2 acts non-redundantly to control the processes of nephron segmentation through an Rbp-J-dependent process. Notch1 and Notch2 are detected in the early renal vesicle. Genetic analysis reveals that only Notch2 is required for the differentiation of proximal nephron structures (podocytes and proximal convoluted tubules)despite the presence of activated Notch1 in the nuclei of putative proximal progenitors. The inability of endogenous Notch1 to compensate for Notch2 deficiency may reflect sub-threshold Notch1 levels in the nucleus. In line with this view, forced expression of a γ-secretase-independent form of Notch1 intracellular domain drives the specification of proximal fates where all endogenous, ligand-dependent Notch signaling is blocked by aγ-secretase inhibitor. These results establish distinct (non-redundant),instructive roles for Notch receptors in nephron segmentation.

1 August 2005 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
Kameswaran SurendranKameswaran Surendran
Kameswaran Surendran
SSSusan Schiavi
Susan Schiavi
KHKeith A. Hruska
Keith A. Hruska
β-Catenin functions as a transducer of Wnt signals to the nucleus, where it interacts with the T cell factor (TCF) family of DNA binding proteins to regulate gene expression. On the basis of the genes regulated by β-catenin and TCF in various biologic settings, two predicted functions of β-catenin/TCF-dependent transcription are to mediate the loss of epithelial polarity and to promote fibroblast activities, such as the increased synthesis of fibronectin during chronic renal disease. These predictions were tested by determination of the expression and function of an inhibitor of Wnt signaling, secreted frizzled-related protein 4 (sFRP4), during renal tubular epithelial injury initiated by unilateral ureteral obstruction (UUO). Despite increased sFRP4 gene expression in perivascular regions of injured kidneys, total sFRP4 protein levels decreased after injury. The decreased sFRP4 protein levels after UUO accompanied increased Wnt-dependent β-catenin signaling in tubular epithelial and interstitial cells, along with increased expression of markers of fibrosis. Administration of recombinant sFRP4 protein caused a reduction in tubular epithelial β-catenin signaling and suppressed the progression of renal fibrosis, as evidenced by a partial maintenance of E-cadherin mRNA expression and a reduction in the amount of fibronectin and α-smooth muscle actin proteins. Furthermore, recombinant sFRP4 reduced the number of myofibroblasts, a central mediator of fibrosis. It is concluded that β-catenin signaling is activated in tubular epithelial and interstitial cells after renal injury, and recombinant sFRP4 can interfere with epithelial de-differentiation and with fibroblast differentiation and function during progression of renal fibrosis.

1 October 2006 in Journal of the American Society of Nephrology
Verified
Journal Article
Closed access
PDF file
CLChun-Liang Lin
Chun-Liang Lin
JWJeng-Yi Wang
Jeng-Yi Wang
YHYu-Ting Huang
Yu-Ting Huang
YKYu-Hsia Kuo
Yu-Hsia Kuo
Kameswaran SurendranKameswaran Surendran
Kameswaran Surendran
FWFeng-Sheng Wang
Feng-Sheng Wang
Glomerulosclerosis and diabetic nephropathy are attributable to high glucose induction of mesangial cell apoptosis. Whereas Wnt signaling has been found to regulate renal morphogenesis and pathogenesis, the biologic role of Wnt/β-catenin signaling in controlling high glucose–induced mesangial cell apoptosis is not well defined. Herein is reported that Wnt/β-catenin signaling is required for protecting glomerular mesangial cells from high glucose–mediated cell apoptosis. High glucose downregulated Wnt4 and Wnt5a expression and the subsequent nuclear translocation of β-catenin, whereas it increased glycogen synthase kinase-3β (GSK-3β) and caspase-3 activities and apoptosis of glomerular mesangial cells. Suppression of GSK-3β activation or increase in nuclear β-catenin by transfection of Wnt4 or Wnt5a or stable β-catenin (S33Y) reversed Akt activation and reduced the high glucose–mediated caspase-3 cleavage and cell apoptosis. Pharmacologic inhibition of GSK-3β by recombinant Wnt5a or bromoindirubin-3′-oxime or LiCl increased Akt phosphorylation and β-catenin translocation and abrogated high glucose–mediated proapoptotic activities. Exogenous bromoindirubin-3′-oxime treatment reduced phospho-Ser9-GSK-3β and β-catenin expression and apoptosis of cells adjacent to glomeruli in diabetic kidneys and attenuated urinary protein secretion in diabetic rats. Taken together, mesangial cells responded to high glucose by impairing that canonical Wnt pathway to increase proapoptotic activities. Sustaining Wnt/β-catenin signaling is beneficial for promoting survival of mesangial cells that are exposed to high glucose stress.

1 March 2002 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
Kameswaran SurendranKameswaran Surendran
Kameswaran Surendran
SMSean P. McCaul
Sean P. McCaul
TSTheodore C. Simon
Theodore C. Simon
Wnt-4 is a secreted glycoprotein that is critical for genitourinary development but found only in the most distal collecting duct epithelium in the normal murine adult kidney. Wnt4 expression is induced throughout the collecting ducts in four murine models of renal injury that produce tubulointerstitial fibrosis: folic acid-induced nephropathy, unilateral ureteral obstruction, renal needle puncture, and genetic polycystic kidney disease. Wnt4 activation induced by injury is limited to collecting ducts, with initial activation in the collecting duct epithelium followed by activation in fibrotic lesions surrounding the collecting ducts. The highest cellular Wnt4 expression is in interstitial fibroblasts in the fibrotic lesions that also express high levels of collagen-α1(I) mRNA and α-smooth muscle actin. In support of a functional role for Wnt-4 in these activated myofibroblasts, Wnt-4 induces stabilization of cytosolic β-catenin in a cultured myofibroblast cell line. Furthermore, Wnt-4-producing fibroblasts placed under the renal capsule of adult mice induce lesions with tubular epithelial destruction. These observations suggest a role for Wnt-4 in the pathogenesis of renal fibrosis.

22 March 2012 in PLOS Genetics
Verified
Journal Article
Open access
PDF file
Xiaolin TuXiaolin Tu
Xiaolin Tu
JCJianquan Chen
Jianquan Chen
JLJoohyun Lim
Joohyun Lim
CKCourtney Karner
Courtney Karner
SLSeung-Yon Lee
Seung-Yon Lee
FLFanxin Long
Fanxin Long
Notch signaling between neighboring cells controls many cell fate decisions in metazoans both during embryogenesis and in postnatal life. Previously, we uncovered a critical role for physiological Notch signaling in suppressing osteoblast differentiation in vivo. However, the contribution of individual Notch receptors and the downstream signaling mechanism have not been elucidated. Here we report that removal of Notch2, but not Notch1, from the embryonic limb mesenchyme markedly increased trabecular bone mass in adolescent mice. Deletion of the transcription factor RBPjk, a mediator of all canonical Notch signaling, in the mesenchymal progenitors but not the more mature osteoblast-lineage cells, caused a dramatic high-bone-mass phenotype characterized by increased osteoblast numbers, diminished bone marrow mesenchymal progenitor pool, and rapid age-dependent bone loss. Moreover, mice deficient in Hey1 and HeyL, two target genes of Notch-RBPjk signaling, exhibited high bone mass. Interestingly, Hey1 bound to and suppressed the NFATc1 promoter, and RBPjk deletion increased NFATc1 expression in bone. Finally, pharmacological inhibition of NFAT alleviated the high-bone-mass phenotype caused by RBPjk deletion. Thus, Notch-RBPjk signaling functions in part through Hey1-mediated inhibition of NFATc1 to suppress osteoblastogenesis, contributing to bone homeostasis in vivo. Osteoporosis is a disease caused by disruption of the balance between bone formation and resorption resulting in a net loss of bone mass. Although anti-resorptive agents are the current mainstay of osteoporosis therapy, novel strategies to promote bone formation are critically needed for more effective prevention and treatment of the disease. Notch signaling, an evolutionally conserved mechanism among multi-cellular organisms, was recently shown to control bone formation and therefore represents a potential target pathway for novel bone-promoting therapeutics. In this study we elucidate the intracellular signaling mechanism through which Notch controls bone formation, providing a molecular framework that may guide future drug development.

1 June 2004 in Kidney International
Verified
Journal Article
Closed access
Kameswaran SurendranKameswaran Surendran
Kameswaran Surendran
TSTheodore C. Simon
Theodore C. Simon
HLHelen Liapis
Helen Liapis
JMJohn K. McGuire
John K. McGuire